JP2007523872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523872A5 JP2007523872A5 JP2006520275A JP2006520275A JP2007523872A5 JP 2007523872 A5 JP2007523872 A5 JP 2007523872A5 JP 2006520275 A JP2006520275 A JP 2006520275A JP 2006520275 A JP2006520275 A JP 2006520275A JP 2007523872 A5 JP2007523872 A5 JP 2007523872A5
- Authority
- JP
- Japan
- Prior art keywords
- controlled release
- drug
- matrix
- soft capsule
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013270 controlled release Methods 0.000 claims 34
- 239000007901 soft capsule Substances 0.000 claims 22
- 239000011159 matrix material Substances 0.000 claims 21
- 229940079593 drug Drugs 0.000 claims 18
- 239000003814 drug Substances 0.000 claims 18
- 239000004480 active ingredient Substances 0.000 claims 14
- 239000007887 hard shell capsule Substances 0.000 claims 11
- 239000000839 emulsion Substances 0.000 claims 10
- 239000012071 phase Substances 0.000 claims 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims 7
- 239000000194 fatty acid Substances 0.000 claims 7
- 229930195729 fatty acid Natural products 0.000 claims 7
- 239000002775 capsule Substances 0.000 claims 6
- 239000004094 surface-active agent Substances 0.000 claims 6
- -1 fatty acid ester Chemical class 0.000 claims 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 5
- 239000007787 solid Substances 0.000 claims 5
- 239000004615 ingredient Substances 0.000 claims 4
- 239000008384 inner phase Substances 0.000 claims 4
- 150000002632 lipids Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 239000008385 outer phase Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 3
- 239000012530 fluid Substances 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 230000001088 anti-asthma Effects 0.000 claims 2
- 239000000924 antiasthmatic agent Substances 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 2
- 239000008206 lipophilic material Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000003607 modifier Substances 0.000 claims 2
- 229960005181 morphine Drugs 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- 239000008158 vegetable oil Substances 0.000 claims 2
- 239000001993 wax Substances 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 230000036760 body temperature Effects 0.000 claims 1
- 239000002327 cardiovascular agent Substances 0.000 claims 1
- 229940125692 cardiovascular agent Drugs 0.000 claims 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 claims 1
- 229960000590 celecoxib Drugs 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 claims 1
- 229960004166 diltiazem Drugs 0.000 claims 1
- 230000009969 flowable effect Effects 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 239000003887 narcotic antagonist Substances 0.000 claims 1
- 230000003533 narcotic effect Effects 0.000 claims 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 claims 1
- 229960001597 nifedipine Drugs 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 229960002085 oxycodone Drugs 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000004926 polymethyl methacrylate Substances 0.000 claims 1
- 229960000278 theophylline Drugs 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48796803P | 2003-07-17 | 2003-07-17 | |
| US60/487,968 | 2003-07-17 | ||
| PCT/US2004/022456 WO2005009409A2 (en) | 2003-07-17 | 2004-07-14 | Controlled release preparations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007523872A JP2007523872A (ja) | 2007-08-23 |
| JP2007523872A5 true JP2007523872A5 (https=) | 2007-10-04 |
| JP5296314B2 JP5296314B2 (ja) | 2013-09-25 |
Family
ID=34102731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520275A Expired - Fee Related JP5296314B2 (ja) | 2003-07-17 | 2004-07-14 | 制御放出製剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20060115527A1 (https=) |
| EP (2) | EP1653931A2 (https=) |
| JP (1) | JP5296314B2 (https=) |
| CN (2) | CN1826100B (https=) |
| AU (2) | AU2004258894B2 (https=) |
| CA (1) | CA2533013C (https=) |
| CY (1) | CY1118182T1 (https=) |
| DK (1) | DK2279729T3 (https=) |
| ES (1) | ES2592504T3 (https=) |
| HR (1) | HRP20161374T1 (https=) |
| HU (1) | HUE031092T2 (https=) |
| LT (1) | LT2279729T (https=) |
| PL (1) | PL2279729T3 (https=) |
| PT (1) | PT2279729T (https=) |
| SI (1) | SI2279729T1 (https=) |
| WO (1) | WO2005009409A2 (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2480826C (fr) | 2002-04-09 | 2012-02-07 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
| ATE482695T1 (de) | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
| US8293270B2 (en) * | 2005-10-26 | 2012-10-23 | Banner Pharmacaps, Inc. | Lipophilic vehicle-based dual controlled release matrix system |
| CA2627292C (en) | 2005-10-26 | 2012-04-17 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| US10960077B2 (en) * | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| FR2901478B1 (fr) * | 2006-05-24 | 2015-06-05 | Flamel Tech Sa | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee |
| US9023400B2 (en) | 2006-05-24 | 2015-05-05 | Flamel Technologies | Prolonged-release multimicroparticulate oral pharmaceutical form |
| EP2042165A1 (de) * | 2007-09-28 | 2009-04-01 | Swiss Caps Rechte und Lizenzen AG | Hot-Melt-Befüllte Weichkapseln |
| JP2011506319A (ja) * | 2007-12-06 | 2011-03-03 | デュレクト コーポレーション | 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法 |
| CA2610819A1 (en) * | 2007-12-12 | 2008-12-02 | Multi Formulations Ltd. | Particles in a capsule |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CA2746887C (en) * | 2008-12-15 | 2016-07-05 | Banner Pharmacaps, Inc. | Methods for enhancing the release and absorption of water insoluble active agents |
| CN102133406B (zh) * | 2011-03-17 | 2013-06-19 | 泰州市康特生物工程有限公司 | 阿片类药物油相制剂及其制备方法 |
| AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| MX2015011163A (es) | 2013-03-15 | 2016-02-17 | Banner Life Sciences Llc | Capsula entericas blandas que no contienen gelatina. |
| CA3042642A1 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US9504656B2 (en) * | 2013-10-21 | 2016-11-29 | Banner Life Sciences, LLC | Pharmaceutical compositions for poorly soluble active ingredients |
| WO2015074898A1 (en) * | 2013-11-19 | 2015-05-28 | Qiagen Gmbh | Method for generating emulsions |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US10744131B2 (en) | 2013-12-31 | 2020-08-18 | Kashiv Biosciences, Llc | Abuse-resistant drug formulations |
| US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
| AU2015222880B2 (en) | 2014-02-28 | 2016-11-24 | Banner Life Sciences Llc | Controlled release enteric soft capsules of fumarate esters |
| US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US10772841B2 (en) | 2014-04-07 | 2020-09-15 | Patheon Softgels Inc. | Opioid abuse-deterrent controlled release formulations |
| US10772842B2 (en) | 2015-01-09 | 2020-09-15 | Patheon Softgels Inc. | Abuse-deterrent opioids |
| US9775814B2 (en) | 2014-06-20 | 2017-10-03 | Patheon Softgels Inc. | Enteric soft capsule compositions |
| US20150366814A1 (en) | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| WO2016057133A1 (en) * | 2014-10-08 | 2016-04-14 | Banner Life Sciences Llc | Controlled release enteric soft capsules of fumarate esters |
| WO2016064873A1 (en) * | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| US10182993B2 (en) | 2015-04-06 | 2019-01-22 | Patheon Softgels Inc. | Compositions for colonic delivery of drugs |
| US20170312226A1 (en) * | 2016-04-28 | 2017-11-02 | Ascent Pharmaceuticals, Inc. | Pharmaceutical dosage forms |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
| WO2019064026A1 (en) * | 2017-09-29 | 2019-04-04 | Orexo Ab | NEW PHARMACEUTICAL COMPOSITIONS |
| AU2018390826B2 (en) | 2017-12-20 | 2024-09-12 | Purdue Pharma L.P. | Abuse deterrent morphine sulfate dosage forms |
| GB201904767D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| GB201904771D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| US11903918B2 (en) | 2020-01-10 | 2024-02-20 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
| GB202109464D0 (en) * | 2021-06-30 | 2021-08-11 | Norwegian Univ Sci & Tech Ntnu | Soft gel capsule |
| PT118579A (pt) * | 2023-03-28 | 2024-09-30 | Inst Politecnico De Coimbra | Hidrocolóide cicatrizante e antimicrobiano à base de galactomanana e seu processo de obtenção |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1015251A (en) * | 1963-03-12 | 1965-12-31 | Glaxo Lab Ltd | Aqueous pharmaceutical compositions in capsule form |
| US4183960A (en) * | 1978-02-01 | 1980-01-15 | Exxon Research & Engineering Co. | Detoxification by means of the controlled, in vivo secretion triggered rupture of liquid membrane capsules |
| IT1101649B (it) * | 1978-12-15 | 1985-10-07 | Lehner Ag | Composizione farmaceutica ad azione prolungata contenente acidi biliari |
| US4249531A (en) * | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
| WO1983001738A1 (en) * | 1981-11-12 | 1983-05-26 | SCHRÖDER, Ulf | Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof |
| DK151608C (da) | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
| DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
| US4882167A (en) * | 1983-05-31 | 1989-11-21 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
| GB8412864D0 (en) * | 1984-05-19 | 1984-06-27 | Smith Kline French Lab | Chemical compounds |
| DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
| US4666716A (en) * | 1984-09-04 | 1987-05-19 | Richardson-Vicks Inc. | Antidiarrheal compositions and use thereof |
| EP0212875A3 (en) * | 1985-08-12 | 1988-06-15 | William Gough Tucker | Medicinal composition and method of making same |
| US4963540A (en) * | 1986-04-16 | 1990-10-16 | Maxson Wayne S | Method for treatment of premenstrual syndrome |
| JPS62249922A (ja) | 1986-04-23 | 1987-10-30 | Toyo Kapuseru Kk | ゼラチンカプセル製剤の有効成分の溶出時間を自在に調節する方法 |
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US4795642A (en) | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
| GB8630273D0 (en) * | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
| US5240712A (en) * | 1987-07-17 | 1993-08-31 | The Boots Company Plc | Therapeutic agents |
| US4902513A (en) * | 1987-07-31 | 1990-02-20 | Jean Carvais | Oral sustained release medicament |
| LU87233A1 (fr) * | 1988-06-07 | 1990-02-28 | Pharlyse Sa | Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation |
| DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
| US5188837A (en) * | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| GB9120672D0 (en) * | 1991-09-28 | 1991-11-06 | Ciba Geigy Ag | Pharmaceutical compositions |
| US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
| US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
| DE4140192C2 (de) * | 1991-12-05 | 1996-02-29 | Alfatec Pharma Gmbh | Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen |
| US5378413A (en) * | 1993-01-21 | 1995-01-03 | The United States Of America As Represented By The Secretary Of The Navy | Process for preparing microcapsules having gelatin walls crosslinked with quinone |
| CA2156726C (en) * | 1993-02-26 | 2000-10-17 | Paula Denise Davis | Bisacodyl dosage form |
| DE4322826A1 (de) * | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmazeutisches Präparat |
| US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
| SI9400338A (en) * | 1994-08-31 | 1996-04-30 | Lek D D | Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules. |
| IL115445A (en) * | 1994-10-17 | 1999-08-17 | Akzo Nobel Nv | Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation |
| US6099864A (en) * | 1994-12-02 | 2000-08-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | In situ activation of microcapsules |
| US5871776A (en) | 1995-01-31 | 1999-02-16 | Mehta; Atul M. | Controlled-release nifedipine |
| US5587149A (en) * | 1995-02-06 | 1996-12-24 | R.P. Scherer Corporation | Topical application emulsions |
| FR2735978B1 (fr) * | 1995-06-30 | 1997-09-19 | Sanofi Sa | Composition pharmaceutique d'amiodarone pour administration parenterale |
| FR2739558B1 (fr) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
| US6132759A (en) * | 1996-05-03 | 2000-10-17 | Innogenetics N.V. | Medicaments containing gelatin cross-linked with oxidized polysaccharides |
| NL1003503C2 (nl) * | 1996-07-04 | 1998-01-07 | Negma Steba International Dev | Farmaceutische samenstelling voor orale toediening. |
| ATE295189T1 (de) * | 1997-06-03 | 2005-05-15 | Innogenetics Nv | Neue arzneimittel auf der basis von polymeren aus mit methacrylamid modifizierter gelatine |
| BE1011363A3 (fr) * | 1997-09-11 | 1999-08-03 | Smb Technology | Capsules semi-solides autoemulsionnables matricielles a action prolongee. |
| US20020013304A1 (en) * | 1997-10-28 | 2002-01-31 | Wilson Leland F. | As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| US5891470A (en) * | 1998-04-17 | 1999-04-06 | Advanced Polymer Systems, Inc. | Softgel formulation containing retinol |
| CN1236813C (zh) * | 1998-12-11 | 2006-01-18 | 药品处理公司 | 水难溶性药物的自乳化组合物 |
| WO2000035419A2 (en) * | 1998-12-17 | 2000-06-22 | Alza Corporation | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| US20020034548A1 (en) * | 1998-12-31 | 2002-03-21 | James Parr | Stabilized ascorbic composition |
| US6372251B2 (en) * | 1999-06-11 | 2002-04-16 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| PT1249231E (pt) * | 2001-04-12 | 2004-06-30 | Vesifact Ag | Formulacoes farmaceuticas contendo substancias activas anti-inflamatorias e sua utilizacao |
| US20030105141A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Finely self-emulsifiable pharmaceutical composition |
| US20030105016A1 (en) * | 2001-09-06 | 2003-06-05 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| US7157103B2 (en) * | 2001-08-06 | 2007-01-02 | Euro-Celtique S.A. | Pharmaceutical formulation containing irritant |
| HUP0401438A3 (en) * | 2001-08-31 | 2008-04-28 | Schering Oy | Drug delivery system |
| FR2832065B1 (fr) * | 2001-11-13 | 2004-11-05 | Besins Int Belgique | Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations |
| EP1455730A4 (en) * | 2001-12-06 | 2006-01-18 | Ranbaxy Lab Ltd | NANOTEHOUS ISOTRETINOINE COMPOSITIONS |
| US6572889B1 (en) | 2002-03-07 | 2003-06-03 | Noveon Ip Holdings Corp. | Controlled release solid dosage carbamazepine formulations |
| EP1344523A1 (en) * | 2002-03-11 | 2003-09-17 | Warner-Lambert Company | Ibuprofen solution for hard gelatin capsules |
| US20040052836A1 (en) * | 2002-09-13 | 2004-03-18 | Li Luk Chiu | Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life |
| US20060134190A1 (en) * | 2004-12-16 | 2006-06-22 | Banner Pharmacaps Inc. | Formulations of bisphosphonate drugs with improved bioavailability |
| US20070010498A1 (en) * | 2005-07-07 | 2007-01-11 | Klaus Theobald | Method for reducing blood loss associated with cardio-pulmonary bypass surgery |
-
2004
- 2004-07-14 CA CA2533013A patent/CA2533013C/en not_active Expired - Fee Related
- 2004-07-14 SI SI200432345A patent/SI2279729T1/sl unknown
- 2004-07-14 LT LTEP10075739.2T patent/LT2279729T/lt unknown
- 2004-07-14 CN CN2004800206901A patent/CN1826100B/zh not_active Expired - Fee Related
- 2004-07-14 EP EP04778128A patent/EP1653931A2/en not_active Withdrawn
- 2004-07-14 ES ES10075739.2T patent/ES2592504T3/es not_active Expired - Lifetime
- 2004-07-14 JP JP2006520275A patent/JP5296314B2/ja not_active Expired - Fee Related
- 2004-07-14 DK DK10075739.2T patent/DK2279729T3/da active
- 2004-07-14 HU HUE10075739A patent/HUE031092T2/en unknown
- 2004-07-14 WO PCT/US2004/022456 patent/WO2005009409A2/en not_active Ceased
- 2004-07-14 EP EP10075739.2A patent/EP2279729B1/en not_active Expired - Lifetime
- 2004-07-14 PL PL10075739T patent/PL2279729T3/pl unknown
- 2004-07-14 CN CN201010559247.9A patent/CN102000042B/zh not_active Expired - Fee Related
- 2004-07-14 AU AU2004258894A patent/AU2004258894B2/en not_active Ceased
- 2004-07-14 PT PT100757392T patent/PT2279729T/pt unknown
-
2006
- 2006-01-17 US US11/275,563 patent/US20060115527A1/en not_active Abandoned
-
2010
- 2010-08-20 AU AU2010212463A patent/AU2010212463A1/en not_active Ceased
-
2014
- 2014-08-15 US US14/460,747 patent/US20150010623A1/en not_active Abandoned
-
2016
- 2016-10-20 HR HRP20161374TT patent/HRP20161374T1/hr unknown
- 2016-11-03 CY CY20161101121T patent/CY1118182T1/el unknown
-
2017
- 2017-09-22 US US15/712,258 patent/US20180008548A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007523872A5 (https=) | ||
| CA2533013A1 (en) | Controlled release preparations | |
| TWI257871B (en) | Pharmaceutical formulation | |
| US9241940B2 (en) | Pharmaceutical composition comprising nanocrystals | |
| US7374779B2 (en) | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents | |
| CA2627292C (en) | Hydrophilic vehicle-based dual controlled release matrix system | |
| US6153218A (en) | Biphasic capsule formulation | |
| CA2627351C (en) | Lipophilic vehicle-based dual controlled release matrix system | |
| JP2018058870A (ja) | 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル | |
| KR940000231B1 (ko) | 2-(2-플루오로-4-비페닐릴)프로피온산을 함유하는 약제학적 조성물의 제조방법 | |
| US20100291197A1 (en) | hot melt-filled soft capsules | |
| JP2007528388A5 (https=) | ||
| JP2013540806A (ja) | バルク腸溶カプセルシェル | |
| AU2001237876A1 (en) | New self emulsifying drug delivery system | |
| TWI897887B (zh) | 非動物性軟膠囊調配物、其製備方法及使用方法 | |
| CA2516448A1 (en) | Method for preparation of an agglomerate using melt agglomeration | |
| JP4974419B2 (ja) | 薬物含有徐放性顆粒およびそれを含む錠剤 | |
| EP2878311A1 (en) | Solubility Enhancement for Hydrophobic Drugs | |
| JP2000302679A (ja) | 軟カプセル剤充填用組成物および軟カプセル剤 | |
| Zvonar et al. | Evaluation of microcapsulesrelease properties influenced by core composition | |
| CZ26744U1 (cs) | Měkké kapsle obsahující farmaceuticky účinné látky špatně rozpustné ve vodě |